Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized antithrombotic therapy in coronary heart disease with diabetes after stenting
ChiCTR1800015104Phase 4Recruiting
- Sponsor
- Department of Cardiology
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in coronary arteriosclerosis comparing Aspirin + clopidogrel with Aspirin + ticagrelor (2 arms). Primary endpoint: Platelet function. Started Mar 2018; status: recruiting.
02
Drugs
ticagrelorclopidogrelaspirin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR1800015104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015104.